Related Experiment Video
Updated: Jun 13, 2026

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Systematic evaluation of mobile element insertions in autosomal dominant hypercholesterolemia genes using short-read
Lisa Jeanpetit1, Corentin Molitor2, Alexandre Janin3
1Service de Biochimie et Biologie Moléculaire, Laboratoire de Biologie Médicale Multisites, Hospices Civils de Lyon, Lyon, France.
Atherosclerosis
|June 11, 2026
Summary
Mobile element insertions (MEIs) are rare causes of autosomal dominant hypercholesterolemia (ADH). This study found MEIs in 0.04% of ADH patients, highlighting their potential role in genetic diagnosis.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Disease
Background:
- Autosomal dominant hypercholesterolemia (ADH) significantly increases cardiovascular risk.
- Short-read next-generation sequencing (NGS) often misses mobile element insertions (MEIs), a known cause of LDLR-related ADH.
- The prevalence and diagnostic utility of MEIs in ADH remain underexplored.
Purpose of the Study:
- To systematically evaluate the contribution of MEIs to ADH in a large patient cohort.
- To assess the frequency and functional impact of MEIs in the LDLR gene.
- To determine the role of MEIs in patients with suspected ADH who are negative for other genetic variants.
Main Methods:
- Retrospective screening of NGS data from 2393 unrelated probands using MELT software for MEIs.
- Orthogonal sequencing for validation of candidate MEI variants.
- Luciferase assays to assess functional consequences of MEIs on LDLR promoter activity.
Main Results:
- An adjusted prevalence of 0.04% (1/2393) for LDLR MEIs in ADH patients was determined.
- One confirmed MEI (AluYb8b1 insertion) was identified, but functional assays classified it as a variant of uncertain significance.
- One false-positive tandem duplication was detected, emphasizing the need for careful validation.
Conclusions:
- LDLR MEIs are extremely rare but can occur in ADH.
- MEIs may provide diagnostic information for ADH patients negative after standard genetic testing.
- Optimized MEI detection pipelines could improve molecular diagnosis of ADH.
